Returns–Not enough quarters yet
These returns are for its stock picks as disclosed on Form 13F: last quarter's holdings, valued at this quarter's prices. They miss trades within each quarter, short positions, options, bonds, cash and fees, so they aren't the returns its clients got.
Top holdings
At the end of June 30, 2026. Change is in shares since the quarter before.2
| Stock | Value | Share of portfolio | Change |
|---|---|---|---|
| RAPPRapport Therapeutics, Inc. | $261.7M | 52.5% | −12.0% |
| SEPNSepterna, Inc. | $208.2M | 41.8% | |
| MAZEMaze Therapeutics, Inc. | $28.4M | 5.7% |
Best picks still held
How each current holding has done since the quarter it first appeared in its filings (up to six years back).
| Stock | Held since | Return since | Now worth |
|---|---|---|---|
| MAZEMaze Therapeutics, Inc. | March 31, 2025 | +171.0% | $28.4M |
| RAPPRapport Therapeutics, Inc. | December 31, 2024 | +134.9% | $261.7M |
Quarter by quarter
| Quarter | Its picks | S&P 500 |
|---|---|---|
| June 30, 2026 | +33.1% | +14.8% |
| March 31, 2026 | −6.6% | −4.6% |
| December 31, 2025 | +21.4% | +2.4% |
| June 30, 2025 | +32.4% | +10.5% |
Sources
Every number on this page points here. Each one links to the public record.
- 1SEC EDGAR: Trv Gp V, LLC Form 13F filingshttps://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1990717&type=13F-HR&dateb=&owner=include&count=40CIK 1990717
- 2SEC: 13F for the quarter ended June 30, 2026https://www.sec.gov/Archives/edgar/data/1990717/000119312526340725/Filed August 10, 2026 · accession 0001193125-26-340725